- Home
- QUIK vs CRVO Comparison
QUIK vs CRVO Comparison
Compare QUIK & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QUIK
- CRVO
- Stock Information
- Founded
- QUIK 1988
- CRVO 2001
- Country
- QUIK United States
- CRVO United States
- Employees
- QUIK N/A
- CRVO N/A
- Industry
- QUIK Semiconductors
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- QUIK Technology
- CRVO Health Care
- Exchange
- QUIK Nasdaq
- CRVO Nasdaq
- Market Cap
- QUIK 87.3M
- CRVO 95.4M
- IPO Year
- QUIK 1997
- CRVO N/A
- Fundamental
- Price
- QUIK $4.60
- CRVO $9.80
- Analyst Decision
- QUIK Strong Buy
- CRVO Strong Buy
- Analyst Count
- QUIK 3
- CRVO 8
- Target Price
- QUIK $11.53
- CRVO $25.43
- AVG Volume (30 Days)
- QUIK 146.2K
- CRVO 1.5M
- Earning Date
- QUIK 05-12-2025
- CRVO 05-13-2025
- Dividend Yield
- QUIK N/A
- CRVO N/A
- EPS Growth
- QUIK N/A
- CRVO N/A
- EPS
- QUIK N/A
- CRVO N/A
- Revenue
- QUIK $20,112,000.00
- CRVO $9,737,974.00
- Revenue This Year
- QUIK $22.56
- CRVO N/A
- Revenue Next Year
- QUIK $21.66
- CRVO N/A
- P/E Ratio
- QUIK N/A
- CRVO N/A
- Revenue Growth
- QUIK N/A
- CRVO 36.29
- 52 Week Low
- QUIK $4.26
- CRVO $1.80
- 52 Week High
- QUIK $16.13
- CRVO $25.69
- Technical
- Relative Strength Index (RSI)
- QUIK 37.20
- CRVO 55.40
- Support Level
- QUIK $4.80
- CRVO $9.03
- Resistance Level
- QUIK $5.32
- CRVO $10.89
- Average True Range (ATR)
- QUIK 0.45
- CRVO 1.90
- MACD
- QUIK 0.04
- CRVO -0.29
- Stochastic Oscillator
- QUIK 29.06
- CRVO 32.37
About QUIK QuickLogic Corporation
QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.